Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
U.S. stock futures declined on Tuesday after a positive close on Monday. Futures of major benchmark indices were trading lower.
Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads.
05:51am, Tuesday, 13'th Jan 2026
Wall Street is split on the stock, and the shares are close to the average price target. Something's got to give.
Revvity says it will exceed 2025 profit forecast range
05:10pm, Monday, 12'th Jan 2026
Revvity said on Monday it expects its 2025 adjusted profit per share to exceed its forecast of $4.90 to $5, as the medical equipment maker benefits from renewed demand for contract research a
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
04:15pm, Monday, 12'th Jan 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 20
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models
10:01am, Monday, 12'th Jan 2026
Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.
Revvity Inc. $RVTY Shares Purchased by SG Americas Securities LLC
05:43am, Monday, 12'th Jan 2026
SG Americas Securities LLC raised its stake in Revvity Inc. (NYSE: RVTY) by 531.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commiss
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
08:00am, Friday, 09'th Jan 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly's high-quality predictive models by making L
Revvity (NYSE:RVTY) and InnovAge (NASDAQ:INNV) Financial Analysis
02:27am, Sunday, 04'th Jan 2026
InnovAge (NASDAQ: INNV - Get Free Report) and Revvity (NYSE: RVTY - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the st
Revvity Advances AI-Driven Scientific Discovery With Signals Xynthetica
09:46am, Friday, 19'th Dec 2025
RVTY unveils Signals Xynthetica, an AI-augmented design platform that links predictive models with real lab data to speed discovery.
Revvity to Present at J.P. Morgan Healthcare Conference
08:00am, Thursday, 18'th Dec 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) will present at the 44th annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT. President and Chief Executiv
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery
08:00am, Tuesday, 16'th Dec 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced the introduction of its forthcoming Signals Xynthetica™ Models-as-a Service (MaaS) AI offering within the Revvity Signals
Federated Hermes Inc. Cuts Position in Revvity Inc. $RVTY
04:35am, Wednesday, 10'th Dec 2025
Federated Hermes Inc. lowered its stake in shares of Revvity Inc. (NYSE: RVTY) by 9.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchang
Fisher Asset Management LLC Decreases Stock Position in Revvity Inc. $RVTY
04:08am, Saturday, 06'th Dec 2025
Fisher Asset Management LLC decreased its stake in shares of Revvity Inc. (NYSE: RVTY) by 74.9% during the undefined quarter, according to the company in its most recent filing with the Securities and
Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
12:53pm, Tuesday, 02'nd Dec 2025
Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Revvity (RVTY) Up 9.5% Since Last Earnings Report: Can It Continue?
12:31pm, Wednesday, 26'th Nov 2025
Revvity (RVTY) reported earnings 30 days ago. What's next for the stock?
